skip to main content
Show Results with:

Results 11 - 20 of 237  for Everything in this catalogue

previous page 1 results 2 3 4 5 next page
Refined by: genre: Article remove author: Watts, Gerald F remove
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Material Type:
Article
Add to My workspace

Statin Toxicity: Mechanistic Insights and Clinical Implications

Ward, Natalie C.; Watts, Gerald F.; Eckel, Robert H.

Circulation research: journal of the American Heart Association. Volume 124:Issue 2 (2019) -- Lippincott Williams & Wilkins -- Highwire Press

Online access

12
Material Type:
Article
Add to My workspace

PCSK9 in HIV infection: New opportunity or red herring?

Ruscica, Massimiliano; Watts, Gerald F.; Sirtori, Cesare R.

Atherosclerosis. Volume 284: (2019, May); pp 216-217 -- Elsevier Ireland Ltd

Online access

13
Material Type:
Article
Add to My workspace

PCSK9 monoclonal antibodies and lipoprotein apheresis for lowering lipoprotein(a): making choices in an era of RNA-based therapies

Ruscica, Massimiliano; Watts, Gerald F; Sirtori, Cesare R

European journal of preventive cardiology. Volume 26:Number 9 (2019); pp 998-1000 -- SAGE Publications

Online access

14
Material Type:
Article
Add to My workspace

What's new on therapies for elevated lipoprotein(a)

Ward, Natalie C.; Schultz, Carl J.; Watts, Gerald F.

Expert review of clinical pharmacology. Volume 12:Number 6 (2019, June 3rd); pp 495-499 -- Informa Plc

Online access

15
Material Type:
Article
Add to My workspace

Icosapent ethyl for dyslipidaemia in patients with diabetes and coronary artery disease: Act now to reduce it

Lan, Nick S. R. et al.

Diabetes, obesity & metabolism. Volume 21:Issue 7 (2019); pp 1734-1736 -- [John Wiley & Sons Ltd]

Online access

16
Material Type:
Article
Add to My workspace

Icosapent ethyl for dyslipidaemia in patients with diabetes and coronary artery disease: Act now to reduce it

Lan, Nick S. R. et al.

Diabetes, obesity & metabolism. Volume 21:Issue 7 (2019); pp 1734-1736 -- [John Wiley & Sons Ltd]

Online access

17
Material Type:
Article
Add to My workspace

Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy

Warden, Bruce A. et al.

Journal of clinical lipidology. Volume 13:Number 4 (2019, July 20th); pp 580-585 -- Elsevier

Online access

18
Material Type:
Article
Add to My workspace

To test, or not to test: that is the question for the future of lipoprotein(a)

Ellis, Katrina L et al.

Expert review of cardiovascular therapy. Volume 17:Number 4 (2019); pp 241-250 -- Taylor & Francis

Online access

19
Material Type:
Article
Add to My workspace

Dyslipidaemia in adults with type 1 diabetes—when to treat?

Lan, Nick S.R. et al.

Diabetes/metabolism research and reviews. Volume 35:Issue 1 (2019); pp n/a-n/a -- John Wiley & Sons

Online access

20
Material Type:
Article
Add to My workspace

Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia

Ellis, Katrina L. et al.

Journal of the American College of Cardiology. Volume 73:Number 9 (2019, March 12th); pp 1029-1039 -- Elsevier Science

Online access

Results 11 - 20 of 237  for Everything in this catalogue

previous page 1 results 2 3 4 5 next page

Refine Search Results

Refine my results

Access Options 

  1. Request to Reading Room  (171)
  2. Online: Reading Room only  (163)
  3. Purchase a copy  (110)
  4. Refine further open sub menu

Creation date 

From To
  1. Before2013  (3)
  2. 2013To2013  (5)
  3. 2014To2014  (8)
  4. 2015To2016  (79)
  5. After 2016  (142)
  6. Refine further open sub menu

Additional Features 

  1. Abstract  (167)
  2. No Abstract  (70)
  3. Refine further open sub menu

Searching Remote Databases, Please Wait